Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Ltd announced board changes effective 31st March 2025. Ms. Pushpa Joshi (DIN: 06838093) was appointed as Additional Non-Executive Independent Director, replacing Ms. Aesha Harsh Shah (DIN: 10423365) who resigned from the same position citing personal reasons. Ms. Joshi is described as an accounting professional with over six years of experience in financial management and office administration, holding diplomas in Tally and accountancy. The Audit Committee and Nomination and Remuneration Committee were also reconstituted to include Ms. Joshi as a member. The company confirmed there are no material reasons behind Ms. Shah's resignation other than those stated in her letter.
This is a routine board-level change with one independent director replacing another for personal reasons. No governance concerns or material impact on operations are indicated, so it is unlikely to have a meaningful effect on shareholders or the stock price.